Details checkedClinical trial listing onlyCheckedregistry

Medical University of Vienna Nimodipine Vestibular Schwannoma Study

Also known as: NiMODipine Injectable Solution, Nimodipine in Vestibular Schwannomas, Nimodipine soaked gel foam pad, NCT04801953

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Therapeutic

Modality

Small Molecule

Stage

Phase 2

Status

Unknown

Target Gene

—

Route / Mode

Intraoperative topical application to cranial nerves

Confidence

82%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

Austria

Population

adult, vestibular-schwannoma, surgery-adjunct

Trial IDs

Mechanism

Phase 2 pilot study applying nimodipine solution intraoperatively to cranial nerves VII and VIII during vestibular schwannoma resection to reduce spasm-related postoperative facial paralysis and deafness.

Indications

Hearing Loss

Notes

Verified as an institution-led surgical-adjunct study rather than a commercial nimodipine hearing-loss program. The registry status is Unknown and the estimated completion date has passed, so HearScape should not present it as active.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, company, allCompanies, isIndustrySponsored, programType, modality, mechanism...

IDs: NCT04801953

Open

Key Events

2021-05-04

Registry lists actual study start for intraoperative nimodipine vestibular schwannoma study

Clinical Trials (1)

NCT04801953

Data Checks